A machine learning PET/CT model shows promise for predicting radiation dose prior to Lu-177 PSMA therapy in prostate cancer patients.
Key Details
- 1Study presented at SNMMI evaluated a machine learning model using F-18 PSMA PET/CT imaging.
- 2Nine patients with metastatic castration-resistant prostate cancer were included, analyzing a total of 57 tumors, 36 salivary glands, and 18 kidneys.
- 3The model used uptake-based PET metrics, radiomic features, and clinical biomarkers for dose prediction.
- 4Predictions closely tracked absorbed dose values obtained from traditional post-therapy dosimetry.
- 5Using pre-therapy PET/CT data could eliminate need for additional scans and reduce patient burden.
- 6The approach is part of a larger, ongoing 5-year research program for validation.
Why It Matters
This approach suggests standard diagnostic imaging can be repurposed with AI to deliver patient-specific radiation dose estimates before therapy, potentially improving safety, efficacy, and workflow efficiency in radiopharmaceutical therapy.
Source
AuntMinnie
Related News
•Radiology Business
AI-Powered Tool Streamlines CT Scan Prioritization in Emergency Departments
An AI-based CT queue system significantly reduces wait times for ED patients by prioritizing scans likely to reveal critical findings.
•Radiology Business
AI Workflow Enables General Radiologists to Match Breast Specialists in Screening
AI-powered workflow helps generalist radiologists detect breast cancer at rates comparable to specialists.
•Radiology Business
LLMs Automate Radiology Report Quality Control, Study Finds
LLM-based systems can rapidly automate radiology report quality control, saving significant manual review time.